Predicted protein targets (top 1)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | BBOX1 | O75936 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL15362810 | 0.74 | MEN1 (0.37) | — | |
| Oxalic Acid SCHEMBL5015060 | 0.70 | BBOX1 (0.31) | BBOX1 | |
| SCHEMBL29456833 | 0.68 | BBOX1 (0.43) | BBOX1 | |
| SCHEMBL28709339 | 0.65 | BBOX1 (0.41) | BBOX1 | |
| SCHEMBL28719655 | 0.65 | BBOX1 (0.41) | BBOX1 | |
| SCHEMBL28719664 | 0.65 | BBOX1 (0.41) | BBOX1 | |
| Bicarbonate SCHEMBL557719 | 0.65 | BBOX1 (0.52) | BBOX1 | |
| Oxalic Acid SCHEMBL5017059 | 0.65 | BBOX1 (0.33) | BBOX1 | |
| SCHEMBL4924122 | 0.65 | BBOX1 (0.43) | BBOX1 | |
| Pivalate SCHEMBL4916733 | 0.64 | BBOX1 (0.46) | BBOX1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-6824928-B2 | NEW COMPOUND EXCELLENT IN SOLUBILITY AGAINST A NONAQUEOUS SOLVENT, AND THE ELECTROLYTES USING THIS COMPOUND ARE HIGH IN ELECTROCONDUCTIVITY | HITACHI, LTD. (JP) | 2004-11-30 | — | — | US | disclosed |
| US-20040053139-A1 | Such as lithium-tetrakis(trifluoroacetate)borate which is highly soluble in solvent of low dielectric constant (ethylene carbonate); improved high-temperature storage; for use in electric appliances/automobiles | HITACHI, LTD. (JP) | 2004-03-18 | — | — | US | disclosed |
| US-20020160273-A1 | Electrolytic cells; mixture of borate and solvent | KANTO KAGAKU KABUSHIKI KAISHA (JP) | 2002-10-31 | — | — | US | disclosed |
| EP-1197494-A2 | New organic borate compounds and the nonaqueous electrolytes and lithium secondary batteries using the compounds | Kanto Kagaku Kabushiki Kaisha (JP) | 2002-04-17 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20020160273-A1 | Electrolytic cells; mixture of borate and solvent | RER1, KCNN3, HCN3 | BBOX1 3500/4885 |
| US-20040053139-A1 | Such as lithium-tetrakis(trifluoroacetate)borate which is highly soluble in solvent of low dielectric constant (ethylene carbonate); improved high-temperature storage; for use in electric appliances/automobiles | MCM3, AP3D1, KCNN3 | BBOX1 4304/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.